This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: E-Na Biotec Inc., Gifu University, Other. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 48 
1 out of 834,513 Years Active: 2020-2021
Title: Yukihiro Akao: Innovator in Oligonucleotide Therapeutics
Introduction
Yukihiro Akao is a prominent inventor based in Gifu, Japan. He has made significant contributions to the field of oligonucleotide therapeutics, holding two patents that showcase his innovative work. His research focuses on developing novel therapeutic agents that can potentially transform treatment methodologies.
Latest Patents
Akao's latest patents include a MicroRNA-143 derivative, which aims to provide novel miR-143 derivatives that can be utilized as oligonucleotide therapeutics. This invention holds promise for advancing therapeutic options in various medical applications. Another notable patent is a double-stranded nucleic acid molecule, which consists of a first polynucleotide chain with a specific base sequence and a complementary second polynucleotide chain. This invention outlines a method for preventing and/or treating tumors through the administration of the double-stranded nucleic acid molecule to a test subject.
Career Highlights
Throughout his career, Yukihiro Akao has worked with E-na Biotec Inc., where he has contributed to the advancement of biotechnological innovations. His work has been instrumental in developing therapeutic solutions that leverage the power of nucleic acids.
Collaborations
Akao has collaborated with notable colleagues, including Yukio Kitade and Mitsuaki Sekiguchi. These collaborations have fostered a productive environment for innovation and
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile